Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-PHORECAST: Eplerenone in Phospholamban-Related Cardiomyopathy
2013-001067-23Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eplerenone in phospholamban-associated cardiomyopathy (PLN-CM) and dilated cardiomyopathy (DCM), sponsored by University Medical Center Groningen. Primary endpoint: Composite primary endpoint of disease progression. Started Nov 2013; status: active.
02
Drugs
eplerenone
03
Conditions
phospholamban-associated cardiomyopathy (PLN-CM)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on 2013-001067-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001067-23.